ALURD (Allurion Technologies) ROCE %: 0.00% (As of Mar. 2026)

What is Allurion Technologies ROCE %?

Allurion Technologies ALURD -2.11% 16 ROCE % is 0.00% as of Mar. 2026. GuruFocus rates ALURD with a GF Score™ of 16/100 and a GF Value™ of $10.66 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Allurion Technologies's annualized ROCE % for the quarter that ended in Mar. 2026 was 0.00%.

Allurion Technologies (OTCPK:ALURD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Allurion Technologies ROCE % Related Terms

Allurion Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for Allurion Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allurion Technologies ROCE % Chart

Allurion Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

-112.64

0.00

-41.67

0.00

Allurion Technologies Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial													52.96	-190.26	-411.72	0.00	0.00

16GF Score

Allurion Technologies Inc ALURD

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Allurion Technologies ROCE % Calculation

Allurion Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-28.681	/	( ( (32.813 - 18.863)	+	(15.772 - 38.445) )	/ 2 )
	=	-28.681	/	( (13.95	+	-22.673)	/ 2 )
	=	-28.681	/	-4.3615
	=	657.59 %

Allurion Technologies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-17.012	/	( ( (15.772 - 38.445)	+	(13.995 - 37.258) )	/ 2 )
	=	-17.012	/	( ( -22.673	+	-23.263 )	/ 2 )
	=	-17.012	/	-22.968
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 0.00% mean?

Allurion Technologies (ALURD) has a ROCE % of 0.00% as of Mar. 2026.

Is Allurion Technologies' ROCE % too high?

Allurion Technologies' current ROCE % is 0.00%. Overall, Allurion Technologies has a GF Score™ of 16/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Allurion Technologies' ROCE % compare to ALRTF and VVOS?

Allurion Technologies' ROCE % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allurion Technologies's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Allurion Technologies stock overvalued right now?

Based on GuruFocus' analysis, Allurion Technologies (ALURD) is currently considered Possible Value Trap. The stock's GF Value™ is $10.66, compared to a current price of $5.91 — trading 44.6% below its estimated fair value. The current ROCE % is 0.00%. Allurion Technologies' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Allurion Technologies (ALURD), the current ROCE % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allurion Technologies (ALURD) Overvalued in 2026?

Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued. The current stock price of $5.91 is trading 44.6% below its estimated GF Value™ of $10.66. GuruFocus considers Allurion Technologies to be Possible Value Trap.

Key valuation signals for ALURD:

ROCE %: 0.00%
GF Value™: $10.66 vs. price of $5.91 (44.6% below fair value)
GF Score™: 16/100 with 4 warning signs

No single metric tells the full story. See the ALURD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allurion Technologies Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies ALRTF VVOS SINT AIDX POAS USAQ NXL TNON PMI NVNO ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Address 11 Huron Drive, Natick, MA, USA, 01760

Website https://www.allurion.com

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

16GF Score

Get the complete analysis for ALURD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.91

Price

$10.66

GF Value

View ALURD Analysis

See ROCE % data for all stocks →